Work

Pexidartinib for advanced tenosynovial giant cell tumor (TGCT): Long-term efficacy and safety from the phase 3 ENLIVEN and phase 1 PLX108-01 (TGCT cohort) studies.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.11042

Authors: Hans Gelderblom, William D. Tap, Emanuela Palmerini, Silvia Stacchiotti, Zev A. Wainberg, Jayesh Desai, John H. Healey, Michiel van de Sande, Nicholas M. Bernthal, Charles Peterfy, Dale Edward Shuster, Qiang Wang, Henry Hsu, Andrew J. Wagner

Institutions: Leiden University Medical Center, Memorial Sloan Kettering Cancer Center, Istituto Ortopedico Rizzoli, Fondazione IRCCS Istituto Nazionale dei Tumori, University of California, Los Angeles, Peter MacCallum Cancer Centre, Daiichi Sankyo (United States), Plexxikon (United States), Dana-Farber Cancer Institute

Language: English

Topic: Musculoskeletal synovial abnormalities and treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2969988214

Cites:

Cited by: 4

Related to: 10